ONCOLYTICS BIOTECH INC. (ONCY) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
16/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseONCY / S&P 11.76% / 15.20% |
LoseONCY / S&P ONCY unavailable / 15.00% |
LoseONCY / S&P ONCY unavailable / 50.40% |
| 2026-Q11/3 |
WinONCY / S&P -2.30% / -4.33% |
LoseONCY / S&P ONCY unavailable / 11.30% |
LoseONCY / S&P ONCY unavailable / 27.70% |
| 2025-Q40/3 |
LoseONCY / S&P -37.86% / 2.65% |
LoseONCY / S&P ONCY unavailable / 9.00% |
LoseONCY / S&P ONCY unavailable / 13.40% |
| 2025-Q31/3 |
WinONCY / S&P 81.82% / 8.12% |
LoseONCY / S&P ONCY unavailable / 4.61% |
LoseONCY / S&P ONCY unavailable / 13.45% |
| 2025-Q21/3 |
WinONCY / S&P 40.00% / 10.94% |
LoseONCY / S&P ONCY unavailable / 4.83% |
LoseONCY / S&P ONCY unavailable / 10.63% |
| 2025-Q10/3 |
LoseONCY / S&P -39.56% / -4.27% |
LoseONCY / S&P ONCY unavailable / 4.98% |
LoseONCY / S&P ONCY unavailable / 10.57% |
| 2024-Q41/3 |
WinONCY / S&P 4.60% / 2.41% |
LoseONCY / S&P ONCY unavailable / 5.25% |
LoseONCY / S&P ONCY unavailable / 6.15% |
| 2024-Q30/3 |
LoseONCY / S&P -12.12% / 5.89% |
LoseONCY / S&P ONCY unavailable / 5.89% |
LoseONCY / S&P ONCY unavailable / 6.11% |
| 2024-Q20/3 |
LoseONCY / S&P -6.60% / 4.28% |
LoseONCY / S&P ONCY unavailable / 5.38% |
LoseONCY / S&P ONCY unavailable / 5.12% |
| 2024-Q10/3 |
LoseONCY / S&P -21.48% / 10.56% |
LoseONCY / S&P ONCY unavailable / 5.71% |
LoseONCY / S&P ONCY unavailable / 5.59% |
| 2023-Q40/3 |
LoseONCY / S&P -38.07% / 11.69% |
LoseONCY / S&P ONCY unavailable / 6.81% |
LoseONCY / S&P ONCY unavailable / 7.78% |
| 2023-Q30/3 |
LoseONCY / S&P -16.15% / -3.27% |
LoseONCY / S&P ONCY unavailable / 7.52% |
LoseONCY / S&P ONCY unavailable / -5.03% |
| 2023-Q21/3 |
WinONCY / S&P 116.67% / 8.74% |
LoseONCY / S&P ONCY unavailable / 9.50% |
LoseONCY / S&P ONCY unavailable / -8.57% |
| 2023-Q10/3 |
LoseONCY / S&P -26.38% / 7.50% |
LoseONCY / S&P ONCY unavailable / 10.77% |
LoseONCY / S&P ONCY unavailable / -15.69% |
| 2022-Q41/3 |
WinONCY / S&P 32.52% / 7.56% |
LoseONCY / S&P ONCY unavailable / 11.88% |
LoseONCY / S&P ONCY unavailable / -17.99% |
| 2022-Q31/3 |
WinONCY / S&P 21.78% / -4.88% |
LoseONCY / S&P ONCY unavailable / 13.47% |
LoseONCY / S&P ONCY unavailable / -1.41% |
| 2022-Q20/3 |
LoseONCY / S&P -36.08% / -16.10% |
LoseONCY / S&P ONCY unavailable / 13.71% |
LoseONCY / S&P ONCY unavailable / 11.04% |
| 2022-Q11/3 |
WinONCY / S&P 13.67% / -4.60% |
LoseONCY / S&P ONCY unavailable / 15.97% |
LoseONCY / S&P ONCY unavailable / 42.23% |
| 2021-Q40/3 |
LoseONCY / S&P -33.49% / 11.03% |
LoseONCY / S&P ONCY unavailable / 15.00% |
LoseONCY / S&P ONCY unavailable / 96.40% |
| 2021-Q30/3 |
LoseONCY / S&P -24.55% / 0.58% |
LoseONCY / S&P ONCY unavailable / 10.77% |
LoseONCY / S&P ONCY unavailable / 69.42% |
| 2021-Q20/3 |
LoseONCY / S&P -27.30% / 8.55% |
LoseONCY / S&P ONCY unavailable / 6.58% |
LoseONCY / S&P ONCY unavailable / 51.81% |
| 2021-Q11/3 |
WinONCY / S&P 60.08% / 6.17% |
LoseONCY / S&P ONCY unavailable / -1.06% |
LoseONCY / S&P ONCY unavailable / 7.39% |
| 2020-Q41/3 |
WinONCY / S&P 40.83% / 12.15% |
LoseONCY / S&P ONCY unavailable / -3.72% |
LoseONCY / S&P ONCY unavailable / -33.42% |
| 2020-Q30/3 |
LoseONCY / S&P -10.11% / 8.93% |
LoseONCY / S&P ONCY unavailable / -2.04% |
LoseONCY / S&P ONCY unavailable / -27.10% |
| 2020-Q21/3 |
WinONCY / S&P 36.23% / 20.54% |
LoseONCY / S&P ONCY unavailable / -0.46% |
LoseONCY / S&P ONCY unavailable / -27.11% |
| 2020-Q10/3 |
LoseONCY / S&P -71.01% / -19.60% |
LoseONCY / S&P ONCY unavailable / 3.47% |
LoseONCY / S&P ONCY unavailable / -14.75% |
| 2019-Q41/3 |
WinONCY / S&P 735.09% / 9.07% |
LoseONCY / S&P ONCY unavailable / 5.36% |
LoseONCY / S&P ONCY unavailable / 2.99% |
| 2019-Q30/3 |
LoseONCY / S&P -66.47% / 1.70% |
LoseONCY / S&P ONCY unavailable / 5.02% |
LoseONCY / S&P ONCY unavailable / 0.21% |
| 2019-Q20/3 |
LoseONCY / S&P -8.60% / 4.30% |
LoseONCY / S&P ONCY unavailable / 6.64% |
LoseONCY / S&P ONCY unavailable / 8.65% |
| 2019-Q10/3 |
LoseONCY / S&P 2.76% / 13.65% |
LoseONCY / S&P ONCY unavailable / 8.12% |
LoseONCY / S&P ONCY unavailable / 14.29% |
| 2018-Q40/3 |
LoseONCY / S&P -53.11% / -13.52% |
LoseONCY / S&P ONCY unavailable / 9.05% |
LoseONCY / S&P ONCY unavailable / 18.23% |
| 2018-Q30/3 |
LoseONCY / S&P -29.82% / 7.71% |
LoseONCY / S&P ONCY unavailable / 10.21% |
LoseONCY / S&P ONCY unavailable / 19.06% |
| 2018-Q21/3 |
WinONCY / S&P 13.52% / 3.43% |
LoseONCY / S&P ONCY unavailable / 9.03% |
LoseONCY / S&P ONCY unavailable / 14.46% |
| 2018-Q10/3 |
LoseONCY / S&P -10.53% / -0.76% |
LoseONCY / S&P ONCY unavailable / 7.68% |
LoseONCY / S&P ONCY unavailable / 12.46% |
| 2017-Q41/3 |
WinONCY / S&P 9.62% / 6.64% |
LoseONCY / S&P ONCY unavailable / 7.03% |
LoseONCY / S&P ONCY unavailable / 13.82% |
| 2017-Q31/3 |
WinONCY / S&P 30.00% / 4.48% |
LoseONCY / S&P ONCY unavailable / 5.68% |
LoseONCY / S&P ONCY unavailable / 17.57% |
| 2017-Q20/3 |
LoseONCY / S&P -9.09% / 3.09% |
LoseONCY / S&P ONCY unavailable / 4.83% |
LoseONCY / S&P ONCY unavailable / 17.74% |
| 2017-Q11/3 |
WinONCY / S&P 109.52% / 6.07% |
LoseONCY / S&P ONCY unavailable / 3.67% |
LoseONCY / S&P ONCY unavailable / 13.32% |
| 2016-Q40/3 |
LoseONCY / S&P -22.22% / 3.82% |
LoseONCY / S&P ONCY unavailable / 2.09% |
LoseONCY / S&P ONCY unavailable / 7.05% |
| 2016-Q30/3 |
LoseONCY / S&P -30.77% / 3.85% |
LoseONCY / S&P ONCY unavailable / 0.20% |
LoseONCY / S&P ONCY unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ONCY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -18.27% | 20.78% |
| Annualized return | -18.27% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | ONCY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -63.04% | 83.14% |
| Annualized return | -18.05% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | ONCY total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -65.59% | 319.30% |
| Annualized return | -10.12% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |